Search the Community

The land that is now the site of The University of Texas Health Science Center at Tyler has a rich history of commitment and dedication to patient care and community health. From its early beginnings in 1943 as the 1,000-bed Camp Fannin Army hospital site during World War II through decades of fighting against pulmonary diseases like tuberculosis, chronic obstructive pulmonary disease, and asbestosis, UT Health Science Center has served the citizens of Texas with distinction. Great strides have been made in subsequent years, advancing healthcare through biomedical research one discovery at a time in scientific areas including lung injury and repair, infectious lung diseases, and cancer, to name just a few ongoing research projects. Today, the biomedical research conducted at UT Health Science Center is nationally recognized and competitively funded by private foundations, non-profit organizations, the Centers for Disease Control, and the gold standard of research support – the National Institutions of Health. As UT Health Science Center continues to make its dreams a reality, the tradition of excellence and public service that began with a barracks hospital 75 years ago remains a core commitment today. With exceptional patient care, comprehensive education, and innovative research, The University of Texas Health Science Center at Tyler and UT Health East Texas combine to serve as the university medical center for Northeast Texas and beyond. A shield defends our communities in Northeast Texas. It protects our health today and safeguards our health and wellness for the future. It stands stalwart between the people we care about and the illnesses, epidemics, and hazards that threaten them. That shield is The University of Texas Health Science Center at Tyler. Our academic mission is a shield forged of three parts – graduate medical education, graduate education, and biomedical and clinical research. Three integral, interconnected components joined unlike anywhere else in Northeast Texas. As the region's only university medical center, UT Health Science Center is home to some of the latest developments in patient care and community health, medical and health education, and biomedical and clinical research. Only about five percent of hospitals qualify as university medical centers. However, this small group of elite institutions is our nation's primary conduit between first-rate patient care, education, research, and the communities we serve. There is a physician shortage in rural counties throughout Northeast Texas. That is why the UT Health Science Center trains the next generation of doctors. Both locally and globally, new and familiar diseases continue to threaten countless lives. That is why UT Health Science Center conducts biomedical and clinical research and trains much-needed future scientists to understand and combat these diseases and infections. Complex problems require sophisticated, modern solutions. That is why UT Health Science Center trains graduate biotechnology students to lead the innovation revolution at the forefront of modern science. Northeast Texas is the sickest and most rural region in the state with profoundly unfavorable health disparities. That is why UT Health Science Center trains public health graduate students to establish systematic, long-term health education and wellness initiatives to promote health for those who need these programs the most. This comprehensive approach makes UT Health Science Center the first and best hope to fortify the long-term health and wellness of Northeast Texas. The challenges we face are significant, but our resolve is more significant at the UT Health Science Center. Every day at The University of Texas Health Science Center at Tyler, we look to our mission and vision to guide our education, research, and patient care initiatives. In partnership with communities across our region, we are improving individuals' and communities' health. We will be a great institution, unified in common purpose, to benefit human health and improve life quality.h other universities, industries, and businesses. The office coordinates externally funded research projects that support research development, post-award management, and technology commercialization. It represents the UT System's interests, the university president, and the university community in their relationships with external funding agencies and sponsors. View full university

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back over 100 years. The ICR is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery. We are world leaders in identifying cancer genes, discovering cancer drugs, and developing precision radiotherapy. Together with our hospital partner, The Royal Marsden NHS Foundation Trust, we are rated in the top four centers for cancer research and treatment worldwide. As well as a world-class research institute, the ICR is a higher education institution and a college of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework(REF 2014). The ICR has charitable status and relies on support from partner organizations, charities, donors, and the general public. He ICR was founded in 1909 as The Cancer Hospital Research Institute, a small research laboratory within The Royal Marsden in Chelsea. Prince Arthur officially opened it, Duke of Connaught and Strathearn, in 1911 during his visit to award The Royal Marsden its Royal Charter. When the NHS was formed in 1948, the ICR became independent from The Royal Marsden, requiring a legal separation of the two organizations. However, the ICR still works in close partnership with the hospital, allowing us to have a unique ‘bench-to-bedside’ approach. Together, the two organizations are rated in the top four centers for cancer research and treatment in the world. Throughout the ICR’s history, the organization has grown substantially, and in the 1930s, expanded into larger premises at its current location in 237 Fulham Road. Alongside The Royal Marsden, we expanded to a second London site in Sutton in the 1950s to work on the new field of nuclear medicine, creating a center of excellence in medical physics and radiotherapy. Right from the start, ICR researchers have made pioneering discoveries that have helped drive forward cancer research worldwide and had significant benefits for patients. In the 1920s and 30s, our scientists made some of the first discoveries of carcinogenic compounds in coal tar. Throughout the 1930s, 40s, and 50s, ICR researchers carried out crucial early work on the role of chemotherapy, developing melphalan and chlorambucil – two drugs still used to treat cancer today. In the 1960s, ICR researchers provided the first conclusive evidence that DNA damage is the fundamental cause of cancer, and showed the essential role of the thymus in our immune systems – a discovery that helped pave the way to modern immunotherapy. The ICR believes Big Data has the potential to transform the cancer research landscape. To properly seize the opportunities offered, we need new approaches to data collection, curation and analysis, and support for infrastructure, education, and training. The ICR believes it is essential for UK science to continue to welcome researchers from across the UK and worldwide to work in this country. A statement on the regulation and transparency of clinical trials from The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust. The ICR believes the EU’s system of pediatric investigational plans (PIPs) needs to be revised to ensure cancer drugs developed for adults are also tested in children whenever their mechanism of action suggests they could be useful. View full university